Eurofarma Looks To Innovate

January 2008 | Company News Alert

Eurofarma, Brazil's sixth largest drugmaker, has seen sales driven by generics over the past few years. The company has experienced year-on-year (y-o-y) sales growth of 15-20% over the past few years largely thanks to generics, which now account for around 18% of overall revenues. However, according to Director of Innovation, Wolney Alonso, the company hopes to change strategy to reduce its reliance on generics, which made up an estimated 14.4% of Brazil's US$12.9bn pharmaceutical market in

If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.